目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 43)
1.1 STUDY OBJECTIVES?
1.2 MARKET DEFINITION?
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 IN VITRO DIAGNOSTICS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED?
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS?
1.5 SUMMARY OF CHANGES?

2 RESEARCH METHODOLOGY (Page No. - 48)
2.1 RESEARCH APPROACH?
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION?
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: ROCHE DIAGNOSTICS (2021)
FIGURE 8 SUPPLY-SIDE ANALYSIS: IN VITRO DIAGNOSTICS MARKET (2021)
FIGURE 9 IVD MARKET: TOP-DOWN APPROACH
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF THE IVD INDUSTRY (2022-2027)
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE IN VITRO DIAGNOSTICS MARKET
2.3 DATA TRIANGULATION APPROACH?
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION?
2.5 STUDY ASSUMPTIONS?
2.6 LIMITATIONS?
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT?
TABLE 2 RISK ASSESSMENT: IN VITRO DIAGNOSTICS MARKET

3 EXECUTIVE SUMMARY (Page No. - 62)
FIGURE 13 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 15 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 16 IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF IVD MARKET

4 PREMIUM INSIGHTS (Page No. - 66)
4.1 IN VITRO DIAGNOSTICS MARKET OVERVIEW?
FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GROWING ADOPTION OF TECHNOLOGICALLY ADVANCED ANALYZERS TO DRIVE MARKET
4.2 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)?
FIGURE 19 REAGENTS & KITS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES?
FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC MIX?
FIGURE 21 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.5 IN VITRO DIAGNOSTICS MARKET: EMERGING VS. DEVELOPED MARKETS?
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 70)
5.1 INTRODUCTION?
5.2 MARKET DYNAMICS?
FIGURE 23 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing geriatric population and subsequent rise in chronic & infectious diseases
TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019-2050)
5.2.1.2 Gradual shift from centralized testing to point-of-care testing
5.2.1.3 Growing awareness of early disease diagnosis in emerging economies
5.2.1.4 Emergence of rapid PoC technologies and rising adoption of automated analyzers
TABLE 4 IN VITRO DIAGNOSTICS MARKET: PRODUCT LAUNCHES (2020−2022)
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario
5.2.3 OPPORTUNITIES
5.2.3.1 Introduction of disease-specific biomarkers and tests
TABLE 5 APPLICATION OF CANCER BIOMARKERS IN CLINICAL PRACTICE
5.2.3.2 Growing significance of companion diagnostics
5.2.3.3 Growth opportunities in emerging markets
TABLE 6 RECENT DEVELOPMENTS IN EMERGING MARKETS
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory & legal guidelines
FIGURE 24 IVDR: KEY AREAS OF IMPACT
5.2.4.2 Operational barriers
TABLE 7 IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3 INDUSTRY TRENDS?
5.3.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
5.3.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING
5.3.3 RISING NUMBER OF REAGENT RENTAL AGREEMENTS
5.3.4 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
FIGURE 25 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
5.4 PORTER’S FIVE FORCES ANALYSIS?
TABLE 8 PORTER’S FIVE FORCES ANALYSIS: IN VITRO DIAGNOSTICS MARKET
5.4.1 INTENSITY OF COMPETITIVE RIVALRY
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 THREAT OF NEW ENTRANTS
5.4.5 THREAT FROM SUBSTITUTES
5.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS?
TABLE 9 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6 REGULATORY ANALYSIS?
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 10 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 26 US: REGULATORY PROCESS FOR IVD DEVICES
5.6.1.2 Canada
FIGURE 27 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA
5.6.2 EUROPE
TABLE 11 EUROPE: CLASSIFICATION OF IVD DEVICES
FIGURE 28 EUROPE: IVDR TIMELINE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
FIGURE 29 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
TABLE 12 JAPAN: CLASSIFICATION OF IVD REAGENTS IN JAPAN
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.3.2 China
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.3.3 India
FIGURE 30 INDIA: REGULATORY PROCESS FOR IVD DEVICES
5.6.3.4 South Korea
TABLE 15 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.3.5 Indonesia
TABLE 16 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES
5.6.4 RUSSIA
TABLE 17 RUSSIA: CLASSIFICATION OF IVD DEVICES
5.6.5 MIDDLE EAST & AFRICA
5.6.5.1 Saudi Arabia
TABLE 18 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.5.2 Africa
5.6.6 LATIN AMERICA
5.6.6.1 Mexico
FIGURE 31 MEXICO: REGULATORY PROCESS FOR IVD DEVICES
TABLE 19 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.6.2 Brazil
5.7 KEY CONFERENCES & EVENTS IN 2023?
TABLE 20 IN VITRO DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.8 PATENT ANALYSIS?
5.8.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 32 TOP PATENT OWNERS AND APPLICANTS: IN VITRO DIAGNOSTICS MARKET (JANUARY 2011-DECEMBER 2022)
FIGURE 33 TOP APPLICANT JURISDICTIONS FOR IVD PATENTS (JANUARY 20211-DECEMBER 2022)
5.8.2 PATENT PUBLICATION TRENDS FOR IN VITRO DIAGNOSTICS MARKET
FIGURE 34 PATENT ANALYSIS: IN VITRO DIAGNOSTICS MARKET(JANUARY 2011-DECEMBER 2022)
TABLE 21 LIST OF PATENTS/PATENT APPLICATIONS IN IVD MARKET, 2021-2022
5.9 TRADE ANALYSIS?
5.9.1 TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS
TABLE 22 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY 2017-2021 (USD MILLION)
TABLE 23 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY 2017-2021 (TONS)
5.10 ECOSYSTEM ANALYSIS?
FIGURE 35 ECOSYSTEM ANALYSIS: IN VITRO DIAGNOSTICS MARKET
5.10.1 IN VITRO DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
5.11 VALUE CHAIN ANALYSIS?
FIGURE 36 VALUE CHAIN ANALYSIS: IN VITRO DIAGNOSTICS MARKET
5.12 SUPPLY CHAIN ANALYSIS?
FIGURE 37 SUPPLY CHAIN ANALYSIS: IN VITRO DIAGNOSTICS MARKET
5.13 PRICING ANALYSIS?
5.13.1 INDICATIVE AVERAGE SELLING PRICE (USD) REGION-WISE: REAGENTS & KITS
5.13.2 AVERAGE SELLING PRICE (USD): IMMUNOASSAY ANALYZERS
5.13.3 AVERAGE SELLING PRICE (USD): LATERAL FLOW ANALYZERS
5.13.4 AVERAGE SELLING PRICE (USD): MOLECULAR DIAGNOSTICS
5.14 TECHNOLOGY ANALYSIS?
5.14.1 KEY TECHNOLOGIES: IN VITRO DIAGNOSTICS MARKET
5.14.2 ADJACENT TECHNOLOGIES: IN VITRO DIAGNOSTICS MARKET
5.15 CASE STUDY?
FIGURE 38 CASE STUDY: MARKET ASSESSMENT AND CONSUMER BUYING BEHAVIOUR IN INDIA
5.16 KEY STAKEHOLDERS & BUYING CRITERIA?
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 39 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF IN VITRO DIAGNOSTIC PRODUCTS
TABLE 24 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF IN VITRO DIAGNOSTIC PRODUCTS (%)
5.16.2 BUYING CRITERIA
FIGURE 40 KEY BUYING CRITERIA FOR IN VITRO DIAGNOSTIC PRODUCTS
TABLE 25 KEY BUYING CRITERIA FOR IN VITRO DIAGNOSTIC PRODUCTS
5.17 IMPACT OF RECESSION ON IVD MARKET (2021-2024)?
5.18 IMPACT OF IN VITRO DIAGNOSTIC REGULATIONS (IVDR) ON LABORATORY TESTING?

6 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE (Page No. - 111)
6.1 INTRODUCTION?
TABLE 26 IN VITRO DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
6.2 REAGENTS & KITS?
6.2.1 GROWING DEMAND FOR RAPID AND POINT-OF-CARE DIAGNOSTICS TO DRIVE MARKET
TABLE 27 IVD MARKET FOR REAGENTS & KITS, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 INSTRUMENTS?
TABLE 28 KEY INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 29 IVD MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 30 IVD MARKET FOR INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
6.3.1 FULLY AUTOMATED INSTRUMENTS
6.3.1.1 Rising availability of technologically advanced analyzers to drive market
TABLE 31 IVD MARKET FOR FULLY AUTOMATED INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
6.3.2 SEMI-AUTOMATED INSTRUMENTS
6.3.2.1 Compact design and cost-effectiveness over automated analyzers to support market growth
TABLE 32 IVD MARKET FOR SEMIAUTOMATED INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 33 IVD MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 DATA MANAGEMENT SOFTWARE?
6.4.1 GROWING ADOPTION OF AUTOMATED ANALYZERS AND RISING NEED FOR EFFECTIVE DATA MANAGEMENT TO DRIVE MARKET
TABLE 34 KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN IVD MARKET
TABLE 35 IVD MARKET FOR DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 SERVICES?
6.5.1 RISING NEED TO ENSURE EFFECTIVE UTILISATION OF IVD PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 36 IVD MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)

7 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY (Page No. - 124)
7.1 INTRODUCTION?
TABLE 37 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
7.2 IMMUNOASSAY/IMMUNOCHEMISTRY?
TABLE 38 KEY IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN IVD MARKET
TABLE 39 IVD MARKET FOR IMMUNOASSAY/IMMUNOCHEMISTRY TECHNOLOGY, BY TYPE, 2020-2027 (USD MILLION)
TABLE 40 IVD MARKET FOR IMMUNOASSAY/IMMUNOCHEMISTRY TECHNOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA)
TABLE 41 KEY ELISA ANALYZERS AVAILABLE IN IVD MARKET
TABLE 42 IVD MARKET FOR ELISA, BY TYPE, 2020-2027 (USD MILLION)
TABLE 43 IVD MARKET FOR ELISA, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.1 Chemiluminescence Immunoassays
7.2.1.1.1 Rising technological advancements and continuous product innovations to drive segment growth
TABLE 44 KEY CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN IVD MARKET
TABLE 45 IVD MARKET FOR CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.2 Fluorescence Immunoassays
7.2.1.2.1 Rising demand for low-cost fluorescent dyes to drive segment growth
TABLE 46 KEY FLUORESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN IVD MARKET
TABLE 47 IVD MARKET FOR FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.3 Colorimetric Immunoassays
7.2.1.3.1 High specificity and easy coagulation to antibodies to drive segment growth
TABLE 48 KEY COLORIMETRIC IMMUNOASSAY SYSTEMS AVAILABLE IN IVD MARKET
TABLE 49 IVD MARKET FOR COLORIMETRIC IMMUNOASSAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2 RADIOIMMUNOASSAYS
7.2.2.1 Usage of RIAs in cancer detection, blood screening, and drug discovery to drive market
TABLE 50 IVD MARKET FOR RADIOIMMUNOASSAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3 RAPID TESTS
7.2.3.1 Rising usage of rapid tests for emergency care to drive market
TABLE 51 KEY RAPID TESTS AVAILABLE IN IVD MARKET
TABLE 52 IVD MARKET FOR RAPID TESTS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.4 WESTERN BLOTTING
7.2.4.1 Widely accepted technique for result validation to support market growth
TABLE 53 KEY WESTERN BLOTTING SYSTEMS AVAILABLE IN IVD MARKET
TABLE 54 IVD MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.5 ENZYME-LINKED IMMUNOSPOT ASSAYS (ELISPOT)
7.2.5.1 High sensitivity and adaptability of technology to fuel market adoption
TABLE 55 IVD MARKET FOR ELISPOT ASSAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 CLINICAL CHEMISTRY?
TABLE 56 CLINICAL CHEMISTRY ANALYZERS FOR HIGH AND MID-VOLUME LABORATORIES
TABLE 57 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES
TABLE 58 KEY BLOOD GAS ANALYZERS AVAILABLE IN IVD MARKET
TABLE 59 IVD MARKET FOR CLINICAL CHEMISTRY, BY TYPE, 2020-2027 (USD MILLION)
TABLE 60 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.1 BASIC METABOLIC PANELS
7.3.1.1 Set of blood tests performed to ascertain common acute conditions
TABLE 61 IVD MARKET FOR BASIC METABOLIC PANELS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.2 LIVER PANELS
7.3.2.1 Panels used to identify and monitor liver diseases & injuries
TABLE 62 IVD MARKET FOR LIVER PANELS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.3 RENAL PROFILES
7.3.3.1 Panels used to monitor cytokines & chemokines in urine
TABLE 63 IVD MARKET FOR RENAL PROFILES, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.4 LIPID PROFILES
7.3.4.1 Lipid panel testing determines total cholesterol and risk status for CVD
TABLE 64 IVD MARKET FOR LIPID PROFILES, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.5 THYROID FUNCTION PANELS
7.3.5.1 Tests performed to determine TSH and thyroglobulin
TABLE 65 IVD MARKET FOR THYROID FUNCTION PANELS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.6 ELECTROLYTE PANELS
7.3.6.1 Prescribed for symptoms such as edema, nausea, and cardiac arrhythmia
TABLE 66 IVD MARKET FOR ELECTROLYTE PANELS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3.7 SPECIALTY CHEMICAL TESTS
7.3.7.1 Test profile includes immunosuppressant drug monitoring and drugs of abuse
TABLE 67 IVD MARKET FOR SPECIALTY CHEMICAL TESTS, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 MOLECULAR DIAGNOSTICS?
TABLE 68 KEY AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE IN IVD MARKET
TABLE 69 IVD MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 70 IVD MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.1 POLYMERASE CHAIN REACTION (PCR)
7.4.1.1 Rising prevalence of infectious & viral diseases to drive market
TABLE 71 KEY PCR INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 72 IVD MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
7.4.2.1 Growing popularity of INAAT and NAAT for infectious disease diagnostics to support market growth
TABLE 73 IVD MARKET FOR INAAT, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.3 HYBRIDIZATION
7.4.3.1 Advanced hybridization & automation of data collection techniques to support market growth
TABLE 74 IVD MARKET FOR HYBRIDIZATION, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
7.4.4.1 Rising demand for personalized medicine to support market growth
TABLE 75 KEY NGS INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 76 IVD MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.5 MICROARRAYS
7.4.5.1 High throughput & resolution capabilities to drive market for protein expression profiling
TABLE 77 IVD MARKET FOR MICROARRAYS, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.6 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
TABLE 78 IVD MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 HEMATOLOGY?
7.5.1 INCREASING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET
TABLE 79 KEY HEMATOLOGY ANALYZERS AVAILABLE IN IVD MARKET
TABLE 80 IVD MARKET FOR HEMATOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
7.6 MICROBIOLOGY?
7.6.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO FUEL MARKET
TABLE 81 KEY MICROBIOLOGY INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 82 IVD MARKET FOR MICROBIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
7.7 COAGULATION & HEMOSTASIS?
7.7.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET
TABLE 83 KEY COAGULATION ANALYZERS AVAILABLE IN IVD MARKET
TABLE 84 KEY POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS AVAILABLE IN IVD MARKET
TABLE 85 IVD MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2020-2027 (USD MILLION)
7.8 URINALYSIS?
7.8.1 RISING PREVALENCE OF KIDNEY DISORDERS AND UTIS TO DRIVE MARKET
TABLE 86 KEY URINALYSIS INSTRUMENTS AVAILABLE IN IVD MARKET
TABLE 87 IVD MARKET FOR URINALYSIS, BY COUNTRY, 2020-2027 (USD MILLION)
7.9 OTHER TECHNOLOGIES?
TABLE 88 KEY BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN IVD MARKET
TABLE 89 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS AVAILABLE IN IVD MARKET
TABLE 90 IVD MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020-2027 (USD MILLION)

8 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION (Page No. - 174)
8.1 INTRODUCTION?
TABLE 91 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.2 INFECTIOUS DISEASES?
8.2.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE ADOPTION OF IVD PRODUCTS
TABLE 92 IVD MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 DIABETES?
8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE ADOPTION OF GLUCOSE MONITORING DEVICES
TABLE 93 COUNTRIES WITH A DIABETIC PATIENT POPULATION, 2021 VS. 2045 (MILLION)
TABLE 94 IVD MARKET FOR DIABETES, BY COUNTRY, 2020-2027 (USD MILLION)
8.4 ONCOLOGY?
8.4.1 RISING INITIATIVES FOR EARLY DETECTION OF CANCER TO DRIVE MARKET
TABLE 95 IVD MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
8.5 CARDIOLOGY?
8.5.1 INCREASING USE OF IMMUNOASSAYS IN DETECTION OF CVD TO DRIVE MARKET
TABLE 96 IVD MARKET FOR CARDIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
8.6 DRUG TESTING/PHARMACOGENOMICS?
8.6.1 INCREASING USE OF TOXICOLOGY TESTING FOR ILLICIT DRUGS TO DRIVE MARKET
TABLE 97 IVD MARKET FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
8.7 HIV/AIDS?
8.7.1 INCREASING USAGE OF REAL-TIME PCR TESTS FOR HIV DETECTION TO DRIVE MARKET
TABLE 98 IVD MARKET FOR HIV/AIDS, BY COUNTRY, 2020-2027 (USD MILLION)
8.8 AUTOIMMUNE DISEASES?
8.8.1 GROWING DEMAND FOR PORTABLE POC DIAGNOSTIC DEVICES TO DRIVE MARKET
TABLE 99 IVD MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2020-2027 (USD MILLION)
8.9 NEPHROLOGY?
8.9.1 INCREASING USE OF BIOMARKERS FOR CKD TO SUPPORT MARKET GROWTH
TABLE 100 IVD MARKET FOR NEPHROLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
8.10 OTHER APPLICATIONS?
TABLE 101 IVD MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)

9 IN VITRO DIAGNOSTICS MARKET, BY END USER (Page No. - 188)
9.1 INTRODUCTION?
TABLE 102 IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
9.2 HOSPITAL LABORATORIES?
9.2.1 RISING NUMBER OF HOSPITALIZATIONS DUE TO INCREASING INFECTIOUS DISEASES TO DRIVE MARKET
TABLE 103 IVD MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
9.3 CLINICAL LABORATORIES?
TABLE 104 IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 105 IVD MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
9.3.1 LARGE REFERENCE LABORATORIES
9.3.1.1 Capability to conduct specific tests such as LDTs with advanced diagnostic tools to drive segment growth
TABLE 106 LARGE REFERENCE LABORATORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9.3.2 MEDIUM-SIZED LABORATORIES
9.3.2.1 Increasing adoption of automated instruments to drive growth of this segment
TABLE 107 MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9.3.3 SMALL LABORATORIES
9.3.3.1 Adoption of point-of-care devices to support segment growth
TABLE 108 SMALL LABORATORIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9.4 POINT-OF-CARE TESTING CENTERS?
9.4.1 RISING DEMAND FOR RAPID TESTING AND AVAILABILITY OF INNOVATIVE POINT-OF-CARE IVD PRODUCTS TO DRIVE MARKET
TABLE 109 IVD MARKET FOR POINT-OF-CARE TESTING CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
9.5 PATIENTS?
9.5.1 USE OF CONVENIENT SELF-TEST KITS TO DRIVE MARKET
TABLE 110 IVD MARKET FOR PATIENTS, BY COUNTRY, 2020-2027 (USD MILLION)
9.6 ACADEMIC INSTITUTES?
9.6.1 RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR PRODUCT DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 111 IVD MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
9.7 OTHER END USERS?
TABLE 112 IVD MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

10 IN VITRO DIAGNOSTICS MARKET, BY REGION (Page No. - 202)
10.1 INTRODUCTION?
FIGURE 41 IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT (2021)
TABLE 113 IN VITRO DIAGNOSTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
10.2 NORTH AMERICA?
FIGURE 42 NORTH AMERICA: IVD MARKET SNAPSHOT
TABLE 114 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 115 NORTH AMERICA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 116 NORTH AMERICA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 117 NORTH AMERICA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 118 NORTH AMERICA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 119 NORTH AMERICA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 120 NORTH AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.2.1 US
10.2.1.1 Established reimbursement framework and favorable policies for IVD providers to drive market
TABLE 121 US: MACROECONOMIC INDICATORS
TABLE 122 US: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 123 US: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 124 US: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 125 US: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 126 US: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 127 US: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising government initiatives & funding for early disease diagnosis to drive market
TABLE 128 CANADA: ESTIMATED PREVALENCE OF DIABETES
TABLE 129 CANADA: MACROECONOMIC INDICATORS
TABLE 130 CANADA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 131 CANADA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 132 CANADA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 133 CANADA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 134 CANADA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 135 CANADA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3 EUROPE?
TABLE 136 EUROPE: IVD MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 137 EUROPE: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 138 EUROPE: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 139 EUROPE: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 140 EUROPE: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 141 EUROPE: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 142 EUROPE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Growing investments in clinical diagnostics research to drive market
TABLE 143 GERMANY: MACROECONOMIC INDICATORS
TABLE 144 GERMANY: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 145 GERMANY: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 146 GERMANY: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 147 GERMANY: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 148 GERMANY: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 149 GERMANY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 High healthcare expenditure and rising investments in genomic medicine to drive market
TABLE 150 FRANCE: MACROECONOMIC INDICATORS
TABLE 151 FRANCE: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 152 FRANCE: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 153 FRANCE: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 154 FRANCE: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 155 FRANCE: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 156 FRANCE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising adoption of genome-based testing and increasing accessibility to IVD tests to drive market
TABLE 157 UK: MACROECONOMIC INDICATORS
TABLE 158 UK: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 159 UK: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 160 UK: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 161 UK: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 162 UK: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 163 UK: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing geriatric population and subsequent rise in chronic conditions to support market growth
TABLE 164 ITALY: MACROECONOMIC INDICATORS
TABLE 165 ITALY: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 166 ITALY: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 167 ITALY: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 168 ITALY: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 169 ITALY: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 170 ITALY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising adoption of technologically advanced immunoassay systems to drive market
TABLE 171 SPAIN: MACROECONOMIC INDICATORS
TABLE 172 SPAIN: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 173 SPAIN: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 174 SPAIN: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 175 SPAIN: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 176 SPAIN: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 177 SPAIN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.6 RUSSIA
10.3.6.1 Rising incidence of non-communicable diseases and government support for medical services to support market growth
TABLE 178 RUSSIA: MACROECONOMIC INDICATORS
TABLE 179 RUSSIA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 180 RUSSIA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 181 RUSSIA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 182 RUSSIA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 183 RUSSIA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 184 RUSSIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 185 REST OF EUROPE: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 186 REST OF EUROPE: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 187 REST OF EUROPE: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 188 REST OF EUROPE: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 189 REST OF EUROPE: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 190 REST OF EUROPE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4 ASIA PACIFIC?
FIGURE 43 ASIA PACIFIC: IVD MARKET SNAPSHOT
TABLE 191 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 192 ASIA PACIFIC: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 193 ASIA PACIFIC: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 194 ASIA PACIFIC: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 195 ASIA PACIFIC: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 196 ASIA PACIFIC: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 197 ASIA PACIFIC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Universal healthcare reimbursement policy and research investments for immunoassays to support market growth
TABLE 198 JAPAN: MACROECONOMIC INDICATORS
TABLE 199 JAPAN: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 200 JAPAN: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 201 JAPAN: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION))
TABLE 202 JAPAN: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 203 JAPAN: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 204 JAPAN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing awareness of preventive care to drive market for advanced & rapid testing platforms
TABLE 205 CHINA: MACROECONOMIC INDICATORS
TABLE 206 CHINA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 207 CHINA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 208 CHINA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 209 CHINA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 210 CHINA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 211 CHINA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising incidence of diabetes and cancer to fuel market growth for IVD products
TABLE 212 INDIA: MACROECONOMIC INDICATORS
TABLE 213 INDIA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 214 INDIA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 215 INDIA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 216 INDIA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 217 INDIA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 218 INDIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Rising healthcare spending for innovative IVD technologies to support market growth
TABLE 219 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 220 SOUTH KOREA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 221 SOUTH KOREA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 222 SOUTH KOREA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 223 SOUTH KOREA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 224 SOUTH KOREA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 225 SOUTH KOREA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.5 INDONESIA
10.4.5.1 Increasing healthcare initiatives and rising burden of infectious diseases to drive market
TABLE 226 INDONESIA: MACROECONOMIC INDICATORS
TABLE 227 INDONESIA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 228 INDONESIA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 229 INDONESIA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 230 INDONESIA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 231 INDONESIA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 232 INDONESIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 233 REST OF ASIA PACIFIC: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 234 REST OF ASIA PACIFIC: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 235 REST OF ASIA PACIFIC: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 236 REST OF ASIA PACIFIC: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 237 REST OF ASIA PACIFIC: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 238 REST OF ASIA PACIFIC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.5 LATIN AMERICA?
TABLE 239 LATIN AMERICA: IVD MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 240 LATIN AMERICA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 241 LATIN AMERICA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 242 LATIN AMERICA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 243 LATIN AMERICA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 244 LATIN AMERICA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 245 LATIN AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Improving healthcare infrastructure to support adoption of IVD products
TABLE 246 BRAZIL: MACROECONOMIC INDICATORS
TABLE 247 BRAZIL: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 248 BRAZIL: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 249 BRAZIL: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 250 BRAZIL: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 251 BRAZIL: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 252 BRAZIL: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Improving accessibility and affordability to healthcare services to support market growth
TABLE 253 MEXICO: MACROECONOMIC INDICATORS
TABLE 254 MEXICO: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 255 MEXICO: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 256 MEXICO: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 257 MEXICO: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 258 MEXICO: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 259 MEXICO: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 260 REST OF LATIN AMERICA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 261 REST OF LATIN AMERICA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 262 REST OF LATIN AMERICA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 263 REST OF LATIN AMERICA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 264 REST OF LATIN AMERICA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION))
TABLE 265 REST OF LATIN AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA?
TABLE 266 MIDDLE EAST & AFRICA: IVD MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 267 MIDDLE EAST & AFRICA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 268 MIDDLE EAST & AFRICA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 269 MIDDLE EAST & AFRICA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 270 MIDDLE EAST & AFRICA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 271 MIDDLE EAST & AFRICA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 272 MIDDLE EAST & AFRICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.6.1 SAUDI ARABIA
10.6.1.1 Rising government healthcare expenditure to support adoption of IVD products
TABLE 273 SAUDI ARABIA: MACROECONOMIC INDICATORS
TABLE 274 SAUDI ARABIA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 275 SAUDI ARABIA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 276 SAUDI ARABIA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 277 SAUDI ARABIA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 278 SAUDI ARABIA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 279 SAUDI ARABIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)
10.6.2 REST OF MIDDLE EAST & AFRICA
TABLE 280 REST OF MIDDLE EAST & AFRICA: IVD MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
TABLE 281 REST OF MIDDLE EAST & AFRICA: IVD INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 282 REST OF MIDDLE EAST & AFRICA: IVD MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 283 REST OF MIDDLE EAST & AFRICA: IVD MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 284 REST OF MIDDLE EAST & AFRICA: IVD MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 285 REST OF MIDDLE EAST & AFRICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 293)
11.1 OVERVIEW?
11.2 STRATEGIES ADOPTED BY KEY PLAYERS?
FIGURE 44 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN IVD MARKET
11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS?
FIGURE 45 REVENUE ANALYSIS FOR KEY PLAYERS IN IVD MARKET
11.4 MARKET SHARE ANALYSIS?
FIGURE 46 IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
TABLE 286 IN VITRO DIAGNOSTICS MARKET: DEGREE OF COMPETITION
11.4.1 MARKET SHARE ANALYSIS, BY TECHNOLOGY
11.4.1.1 Clinical chemistry
FIGURE 47 CLINICAL CHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.2 Immunochemistry/immunoassay analyzers
FIGURE 48 IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.3 Microbiology
FIGURE 49 MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.4 Molecular diagnostics
FIGURE 50 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.5 Hematology
FIGURE 51 HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.6 Coagulation & hemostasis
FIGURE 52 COAGULATION & HEMOSTASIS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.4.1.7 Urinalysis
FIGURE 53 URINALYSIS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
11.5 R&D ASSESSMENT OF KEY PLAYERS?
11.6 COMPETITIVE BENCHMARKING?
TABLE 287 IN VITRO DIAGNOSTIC MARKET: DETAILED LIST OF SMALL & MEDIUM PLAYERS
11.7 COMPANY EVALUATION QUADRANT?
11.7.1 STARS
11.7.2 PERVASIVE PLAYERS
11.7.3 EMERGING LEADERS
11.7.4 PARTICIPANTS
FIGURE 54 IN VITRO DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT 2021
11.8 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS?
11.8.1 PROGRESSIVE COMPANIES
11.8.2 DYNAMIC COMPANIES
11.8.3 STARTING BLOCKS
11.8.4 RESPONSIVE COMPANIES
FIGURE 55 IN VITRO DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & STARTUPS
11.9 COMPANY FOOTPRINT ANALYSIS?
TABLE 288 IVD MARKET: COMPANY FOOTPRINT
TABLE 289 COMPANY FOOTPRINT: BY PRODUCT & SERVICE
TABLE 290 COMPANY FOOTPRINT: BY TECHNOLOGY
TABLE 291 COMPANY FOOTPRINT: BY APPLICATION
TABLE 292 COMPANY FOOTPRINT: BY END USER
11.1 COMPETITIVE SCENARIO?
11.10.1 PRODUCT LAUNCHES & APPROVALS
TABLE 293 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-DECEMBER 2022
11.10.2 DEALS
TABLE 294 DEALS, JANUARY 2019-DECEMBER 2022
11.10.3 OTHER DEVELOPMENTS
TABLE 295 OTHER DEVELOPMENTS, JANUARY 2019-DECEMBER 2022

12 COMPANY PROFILES (Page No. - 314)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS?
12.1.1 ROCHE DIAGNOSTICS
TABLE 296 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 56 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
12.1.2 DANAHER CORPORATION
TABLE 297 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.3 ABBOTT LABORATORIES, INC.
TABLE 298 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 58 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.4 SIEMENS HEALTHINEERS
TABLE 299 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 59 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
12.1.5 SYSMEX CORPORATION
TABLE 300 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 60 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021)
12.1.6 THERMO FISHER SCIENTIFIC, INC.
TABLE 301 THERMO FISHER SCIENTIFIC, INC: BUSINESS OVERVIEW
FIGURE 61 THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT (2021)
12.1.7 BECTON, DICKINSON AND COMPANY
TABLE 302 BD: BUSINESS OVERVIEW
FIGURE 62 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.1.8 BIOMÉRIEUX SA
TABLE 303 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 63 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
12.1.9 BIO-RAD LABORATORIES, INC.
TABLE 304 BIO-RAD LABORATORIES, INC: BUSINESS OVERVIEW
FIGURE 64 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2021)
12.1.10 AGILENT TECHNOLOGIES, INC.
TABLE 305 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 65 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2021)
12.1.11 QIAGEN N.V.
TABLE 306 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 66 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
12.1.12 QUIDEL CORPORATION
TABLE 307 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 67 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.13 DIASORIN S.P.A.
TABLE 308 DIASORIN S.P.A: BUSINESS OVERVIEW
FIGURE 68 DIASORIN S.P.A: COMPANY SNAPSHOT (2021)
12.1.14 ILLUMINA, INC.
TABLE 309 ILLUMINA, INC: BUSINESS OVERVIEW
FIGURE 69 ILLUMINA, INC: COMPANY SNAPSHOT (2021)
12.1.15 HOLOGIC, INC.
TABLE 310 HOLOGIC, INC: BUSINESS OVERVIEW
FIGURE 70 HOLOGIC, INC: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS?
12.2.1 DEVYSER
TABLE 311 DEVYSER: BUSINESS OVERVIEW
FIGURE 71 DEVYSER: COMPANY SNAPSHOT (2021)
12.2.2 PERKINELMER INC.
TABLE 312 PERKINELMER, INC: BUSINESS OVERVIEW
FIGURE 72 PERKINELMER, INC: COMPANY SNAPSHOT (2021)
12.2.3 CHEMBIO DIAGNOSTICS, INC.
TABLE 313 CHEMBIO DIAGNOSTICS, INC: BUSINESS OVERVIEW
FIGURE 73 CHEMBIO DIAGNOSTICS, INC: COMPANY SNAPSHOT (2021)
12.2.4 SURMODICS, INC.
TABLE 314 SURMODICS, INC: BUSINESS OVERVIEW
FIGURE 74 SURMODICS, INC: COMPANY SNAPSHOT (2022)
12.2.5 MENARINI SILICON BIOSYSTEMS
TABLE 315 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
12.2.6 SPEEDX PTY. LTD.
12.2.7 GENSPEED BIOTECH GMBH
12.2.8 ACCELERATE DIAGNOSTICS, INC.
12.2.9 MERCK KGAA
12.2.10 CARIS LIFE SCIENCES, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 454)
13.1 INSIGHTS FROM INDUSTRY EXPERTS?
13.2 DISCUSSION GUIDE?
13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL?
13.4 CUSTOMIZATION OPTIONS?
13.5 RELATED REPORTS?
13.6 AUTHOR DETAILS?